Update: influenza activity--United States, 2003-04 season

    Insights

    Influenza activity surged early in the US during 2003, with severe cases in children. High vaccine demand depleted supplies, prioritizing high-risk groups and suggesting live attenuated influenza vaccine (LAIV) for others.

    Area of Science:

    • Public Health
    • Epidemiology
    • Vaccinology

    Background:

    • Unusually early onset of influenza circulation in the United States for the 2003 season.
    • Anticipated increase in nationwide influenza activity.
    • Reported cases of severe influenza, including fatalities, particularly among children.

    Purpose of the Study:

    • To summarize influenza activity in the United States from October 4 to December 6, 2003.
    • To provide guidance on influenza vaccination strategies given supply constraints.

    Main Methods:

    • Surveillance data collection and reporting of influenza activity to the Centers for Disease Control and Prevention (CDC).
    • Analysis of influenza activity distribution across states.
    • Assessment of trivalent inactivated influenza vaccine (TIV) supply and demand.

    Main Results:

    • Widespread influenza activity reported in 24 states by the week ending December 6, 2003.
    • High and sustained demand for influenza vaccine led to a decreasing supply of TIV.
    • Live, attenuated influenza vaccine (LAIV) remained available.

    Conclusions:

    • Vaccination priority should be given to high-risk individuals, including children aged 6-23 months.
    • Healthy individuals aged 5-49 years are recommended to consider LAIV due to its availability.
    • The early and intense influenza season necessitates strategic vaccine distribution and recommendations.

    Related Concept Videos

    Influenza01:27

    Influenza

    Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
    Vaccinations01:51

    Vaccinations

    Overview
    Inhibitors Of Virion Release01:25

    Inhibitors Of Virion Release

    Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
    Infectious Diseases and Their Occurrence01:28

    Infectious Diseases and Their Occurrence

    Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...